GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (FRA:HE8) » Definitions » EBIT

Aetna (FRA:HE8) EBIT : €4,529 Mil (TTM As of Sep. 2018)


View and export this data going back to . Start your Free Trial

What is Aetna EBIT?

Aetna's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2018 was €1,244 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2018 was €4,529 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aetna's annualized ROC % for the quarter that ended in Sep. 2018 was 10.44%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aetna's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2018 was 7.35%.


Aetna EBIT Historical Data

The historical data trend for Aetna's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna EBIT Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,390.17 3,109.37 4,227.39 4,356.06 2,901.73

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,144.40 523.06 1,260.29 1,501.42 1,244.36

Competitive Comparison of Aetna's EBIT

For the Healthcare Plans subindustry, Aetna's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aetna's EV-to-EBIT Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Aetna's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aetna's EV-to-EBIT falls into.



Aetna EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,529 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna  (FRA:HE8) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aetna's annualized ROC % for the quarter that ended in Sep. 2018 is calculated as:

ROC % (Q: Sep. 2018 )
=NOPAT/Average Invested Capital
=EBIT * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2018 ) + Invested Capital (Q: Sep. 2018 ))/ count )
=4977.456 * ( 1 - 27.43% )/( (34935.1148 + 34256.1754)/ 2 )
=3612.1398192/34595.6451
=10.44 %

where

Invested Capital(Q: Jun. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=49918.496 - 9274.76 - ( 6374.632 - 5% * 13320.216 )
=34935.1148

Invested Capital(Q: Sep. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=48937.271 - 9543.552 - ( 5801.033 - 5% * 13269.788 )
=34256.1754

Note: The EBIT data used here is four times the quarterly (Sep. 2018) data.

2. Joel Greenblatt's definition of Return on Capital:

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aetna's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2018 )
=4529.137/61642.913
=7.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna EBIT Related Terms

Thank you for viewing the detailed overview of Aetna's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (FRA:HE8) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.

Aetna (FRA:HE8) Headlines

No Headlines